Do pre-clinical multiple sclerosis models allow us to measure neurodegeneration and clinical progression?

Tanja Hochstrasser; Zhan Jiangshan; Sebastian Rühling; Christoph Schmitz; Markus Kipp

doi:10.1080/14737175.2018.1459190

Do pre-clinical multiple sclerosis models allow us to measure neurodegeneration and clinical progression?

Expert Rev Neurother. 2018 Apr 4:1-3. doi: 10.1080/14737175.2018.1459190. Online ahead of print.

Authors

Tanja Hochstrasser¹, Zhan Jiangshan¹, Sebastian Rühling¹, Christoph Schmitz¹, Markus Kipp¹

Affiliation

¹ a Department of Anatomy II , Ludwig-Maximilians-University of Munich , Munich , Germany.

PMID: 29589965
DOI: 10.1080/14737175.2018.1459190

No abstract available

Keywords: Brain atrophy; clinical trials; cuprizone; experimental autoimmune encephalomyelitis; neurodegeneration; progressive multiple sclerosis.